nanoTox Adds Presence In Rapidly Expanding North Carolina Nanotechnology Market

Share Article

nanoTox, the first company to provide complete risk assessment exclusively for nanoparticles, announced today that Roxane Smith has been appointed as nanoTox Business Development for North Carolina.

nanoTox, the first company to provide complete risk assessment exclusively for nanoparticles, announced today that Roxane Smith has been appointed as nanoTox Business Development for North Carolina.

nanoTox officials indicate that the use of nanotechnology in various manufacturing processes and product development is exploding. North Carolina is the 2nd largest hub in the US for nanotechnology growth and development. Nanoparticles are being utilized and/or researched in biotechnology, energy, apparel, cosmetics, and many other industries. With the company's focus on nanosafety, it felt that North Carolina is a perfect place for nanoTox, said Harry Bushong, CEO. nanoTox looks forward to working with NC industries to facilitate the safe use of nanotechnology.

Roxane came highly recommended to the nanoTox management team, having worked in the healthcare and biotechnology field for more than 15 years bringing expertise in sales and sales management. nanoTox believes her experience with start-up companies and her unique background make her an excellent addition to the team. As a North Carolina native, Roxane is familiar with the nanotechnology landscape and looks forward to working with and supporting the nanotechnology movement in North Carolina.

About nanoTox
A wholly-owned subsidiary of Nano Risk Assessment, Inc., nanoTox is located in Austin, Texas, and is the first company to provide complete assessment – and solutions – exclusively for nanoparticles. nanoTox determines the toxicity of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, litigation and for acceptance by the insurance industry.

# # #

For more information, visit http://www.nanotox.com.

nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Roxane Smith
nanoTox
704-574-4548
Email >
Visit website